Lung Institute, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
Regenerative Medicine Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
J Pathol. 2022 Jul;257(4):494-500. doi: 10.1002/path.5971. Epub 2022 Jun 17.
The human lung is a relatively quiescent organ in the normal healthy state but contains stem/progenitor cells that contribute to normal tissue maintenance and either repair or remodeling in response to injury and disease. Maintenance or repair lead to proper restoration of functional lung tissue and maintenance of physiological functions, with remodeling resulting in altered structure and function that is typically associated with disease. Knowledge of cell types contributing to lung tissue maintenance and repair/remodeling have largely relied on mouse models of injury-repair and lineage tracing of local progenitors. Therefore, many of the functional alterations underlying remodeling in human lung disease have remained poorly defined. However, the advent of advanced genomics approaches to define the molecular phenotype of lung cells at single-cell resolution has paved the way for rapid advances in our understanding of cell types present within the normal human lung and changes that accompany disease. Here we summarize recent advances in our understanding of disease-related changes in the molecular phenotype of human lung epithelium that have emerged from single-cell transcriptomic studies. We focus attention on emerging concepts of epithelial transitional states that characterize the pathological remodeling that accompanies chronic lung diseases, including idiopathic pulmonary fibrosis, chronic obstructive pulmonary disease, cystic fibrosis, and asthma. Concepts arising from these studies are actively evolving and require corroborative studies to improve our understanding of disease mechanisms. Whenever possible, we highlight opportunities for providing a unified nomenclature in this rapidly advancing field of research. © 2022 The Pathological Society of Great Britain and Ireland.
人类肺部在正常健康状态下是一个相对静止的器官,但含有干细胞/祖细胞,这些细胞有助于正常组织的维持,并在受到损伤和疾病时进行修复或重塑。维持或修复可导致功能性肺组织的适当恢复和生理功能的维持,而重塑则导致结构和功能的改变,这通常与疾病有关。对参与肺组织维持和修复/重塑的细胞类型的了解在很大程度上依赖于损伤修复的小鼠模型和局部祖细胞的谱系追踪。因此,人类肺部疾病重塑的许多功能改变仍然定义不明确。然而,先进的基因组学方法的出现,以单细胞分辨率定义肺细胞的分子表型,为我们理解正常人类肺部内存在的细胞类型以及伴随疾病发生的变化铺平了道路。在这里,我们总结了单细胞转录组研究中对人类肺上皮细胞分子表型与疾病相关变化的最新认识。我们重点关注描述伴随慢性肺部疾病(包括特发性肺纤维化、慢性阻塞性肺疾病、囊性纤维化和哮喘)的病理性重塑的上皮过渡状态的新兴概念。这些研究提出的概念正在不断发展,需要通过对照研究来提高我们对疾病机制的理解。只要有可能,我们将突出在这个快速发展的研究领域中提供统一命名法的机会。 © 2022 大不列颠及爱尔兰病理学学会。